Organon (India) Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
as on 17-06-2024
- Paid Up Capital ₹ 5.98 Cr
as on 17-06-2024
- Company Age 57 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 8.30 Cr
as on 17-06-2024
- Satisfied Charges ₹ 31.90 Cr
as on 17-06-2024
- Revenue 43.86%
(FY 2023)
- Profit 527.81%
(FY 2023)
- Ebitda 410.97%
(FY 2023)
- Net Worth 34.36%
(FY 2023)
- Total Assets 23.47%
(FY 2023)
About Organon (India)
The Corporate was formerly known as Organon (India) Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 5.98 Cr.
The company currently has active open charges totaling ₹8.30 Cr. The company has closed loans amounting to ₹31.90 Cr, as per Ministry of Corporate Affairs (MCA) records.
Anjan Sen, Manjusha Gadgil, and Vikram Chopra serve as directors at the Company.
- CIN/LLPIN
U24231MH1967PTC187949
- Company No.
187949
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Aug 1967
- Date of AGM
20 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Organon (India) Private Limited offer?
Organon (India) Private Limited offers a wide range of products and services, including Common Disease Medicines, Allopathic Cough Syrup, Torex Cough Syrup, Guaiphenesin Cough Syrup.
Who are the key members and board of directors at Organon (India)?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anjan Sen  | Whole-Time Director | 28-May-2021 | Current |
| Manjusha Gadgil | Director | 13-Sep-2022 | Current |
| Vikram Chopra | Director | 28-May-2021 | Current |
Financial Performance and Corporate Structure Insights of Organon (India).
Organon (India) Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 43.86% increase. The company also saw a substantial improvement in profitability, with a 527.81% increase in profit. The company's net worth Soared by an impressive increase of 34.36%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Organon (India)?
In 2022, Organon (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Fulford (India) LimitedActive 76 years 9 monthsAnjan Sen, Manjusha Gadgil and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Anz Grindlays Bank Ltd Creation Date: 22 May 1998 | ₹2.50 Cr | Open |
Ans Grindlays Bank Ltd Creation Date: 17 Dec 1997 | ₹5.00 Cr | Open |
Anz Grindlays Bank Ltd Creation Date: 21 Dec 1996 | ₹7.00 M | Open |
How Many Employees Work at Organon (India)?
Organon (India) has a workforce of 90 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Organon (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Organon (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
